Showing 21 - 30 of 1,109
Persistent link: https://www.econbiz.de/10002843907
Persistent link: https://www.econbiz.de/10003361307
Persistent link: https://www.econbiz.de/10011994052
<Emphasis Type="Bold">Background: The high number of patients with acute myocardial infarction (AMI) has facilitated greater research, resulting in the development of innovative medical devices. So far, results from economic evaluations that compared drug-eluting stents (DES) and bare-metal stents (BMS) have not...</emphasis>
Persistent link: https://www.econbiz.de/10011000748
International comparisons of healthcare costs are growing in importance for a number of different applications. The use of common approaches to converting costs such as GDP purchasing power parities (PPPs) often does not reflect price differences in healthcare in an appropriate manner. This...
Persistent link: https://www.econbiz.de/10005199993
Dramatic increases in health expenditures have led to a substantial number of regulatory interventions in the markets for devices over the last years. However, little attention has been paid thus far to the regulation of medical devices and its effects. This article explores the policies pursued...
Persistent link: https://www.econbiz.de/10005077614
Persistent link: https://www.econbiz.de/10009404302
Persistent link: https://www.econbiz.de/10004800142
Persistent link: https://www.econbiz.de/10013360312
Objective To examine the price reactions of German pharmacies to changes made to OTC drug regulations in 2004. Prior to these changes, regulations guaranteed identical prices in all German pharmacies.Methods Two years after market deregulation, 256 pharmacies were surveyed to determine the...
Persistent link: https://www.econbiz.de/10008455661